Amelia Merrill - Mar 1, 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
SVP, People
Signature
/s/ John G. Saia, as attorney-in-fact for Amelia Merrill
Stock symbol
GH
Transactions as of
Mar 1, 2024
Transactions value $
-$1,233
Form type
4
Date filed
3/4/2024, 06:37 PM
Previous filing
Jan 3, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +158 +0.58% $0.00 27.5K Mar 1, 2024 Direct
transaction GH Common Stock Tax liability -$1.23K -65 -0.24% $18.97 27.5K Mar 1, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -158 -14.3% $0.00 947 Mar 1, 2024 Common Stock 158 $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Amelia Merrill is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter.
F3 Not applicable for Restricted Stock Units.